COMMITTEE MEMBERS & STAFF

Barbara E. Bierer, M.D. is Senior Vice President for Research at the Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. Dr. Bierer, a graduate of Harvard Medical School, completed her internal medicine residency at the Massachusetts General Hospital and her hematology and medical oncology training at the Brigham and Women’s Hospital and the Dana-Farber Cancer Institute. Dr. Bierer maintained a research laboratory in the Department of Pediatric Oncology at Dana-Farber Cancer Institute and was appointed Director of Pediatric Stem Cell Transplantation at Dana-Farber Cancer Institute and Children’s Hospital in 1993. In 1997, she was named Chief of the Laboratory of Lymphocyte Biology at the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. She served on the Scholars Committee of the Howard Hughes Medical Institute and on the Biomedical Research Training Program for Underrepresented Minorities at NHLBI, where she received the Director’s Award in 1999. She returned to the Dana-Farber Cancer Institute in July 2002 as Vice President of Patient Safety and Director of the Center for Patient Safety. In 2003, Dr. Bierer moved to the Brigham and Women’s Hospital to assume her current position. In addition, in 2006, Dr. Bierer established the Center for Faculty Development and Diversity at the Brigham and Women’s Hospital and now serves as its first director.

Dr. Bierer’s laboratory research interests include mechanisms of T cell activation and of immunosuppression, interests that complement her clinical commitment to hematology. In addition to her academic responsibilities, Dr. Bierer was elected to the Board of Directors of the Association for Accreditation of Human Research Protection Programs (AAHRPP), serving as its President from 2003-2007, and was on the Board of Directors of the Federation of American Societies for Experimental Biology (FASEB). She was a member of the Medical and Scientific Advisory Board and, later, the Board of Directors of ViaCell, Inc. She is on the editorial boards of a number of journals including Current Protocols of Immunology. She is currently a member of the AAMC-AAU Advisory Committee on Financial Conflicts of Interest in Clinical Research, on the National Academies of Sciences Committee on Science, Technology and the Law, and on the Secretary’s Advisory Committee for Human Research Protections for which she serves as chair.

Elizabeth H. Blackburn is a leader in the area of telomere and telomerase research. She discovered the molecular nature of telomeres – the ends of eukaryotic chromosomes that serve as protective caps essential for preserving the genetic information – and she discovered the ribonucleoprotein enzyme, telomerase. Blackburn and her research team at the University of California, San Francisco are working with various cells including human cells, with the goal of understanding telomerase and telomere biology.

Blackburn earned her B.Sc. (1970) and M.Sc. (1972) degrees from the University of Melbourne in Australia, and her Ph.D. (1975) from the University of Cambridge in England. She did her postdoctoral work in Molecular and Cellular Biology from 1975 to 1977 at Yale.

In 1978, Blackburn joined the faculty at the University of California, Berkeley in the Department of Molecular Biology. In 1990, she joined the Department of Microbiology and Immunology at the University of California, San Francisco, where she served as department chair from 1993 to 1999. Blackburn is currently a faculty member in the Department of Biochemistry and Biophysics at UCSF. She is also a Non-Resident Fellow at the Salk Institute.

Throughout her career, Blackburn has been honored by her peers as the recipient of many prestigious awards. These include the Eli Lilly Research Award for Microbiology and Immunology (1988), the National Academy of Sciences Award in Molecular Biology (1990), and an Honorary Doctorate of Science from Yale University (1991). She was a Harvey Society Lecturer at the Harvey Society in New York (1990), and the recipient of the UCSF Women’s Faculty Association Award (1995). Most recently, she was awarded the Australia Prize (1998), named California Scientist of the Year in 1999, and awarded the Harvey Prize (1999), the Keio Prize (1999), American Association for Cancer Research-G.H.A. Clowes Memorial Award (2000), American Cancer Society Medal of Honor (2000), AACR-Pezcoller Foundation International Award for Cancer Research (2001), General Motors Cancer Research Foundation Alfred P. Sloan Award (2001), E.B. Wilson Award of the American Society for Cell Biology (2001), 26th Annual Bristol-Myers Squibb Award for Distinguished Achievement in Cancer Research (2003), The Dr. A.H. Heineken Prize for Medicine (2004), The Kirk A. Landon-AACR prize for Basic Cancer Research (2005) and The Albert Lasker Medical Research Award in Basic Medical Research (2006).

Professor Blackburn was elected President of the American Society for Cell Biology in 1998. She is an elected Fellow of the American Academy of Arts and Sciences (1991), the Royal Society of London (1992), the American Academy of Microbiology (1993), and the American Association for the Advancement of Science (2000). She was elected Foreign Associate of the National Academy of Sciences in 1993, and was elected as a Member of the Institute of Medicine in 2000. In 2007 she was named one of Time Magazine’s 100 Most Influential People.

John Burris became president of the Burroughs Wellcome Fund in July 2008. He is the former president of Beloit College. Prior to his appointment at Beloit in 2000, Dr. Burris served for eight years as director and CEO of the Marine Biological Laboratory (MBL) in Woods Hole, Mass. From 1984 to 1992 he was at the National Research Council/National Academies where he served as the executive director of the Commission on Life Sciences. A native of Wisconsin, he received an A.B. in biology from Harvard University in 1971, attended the University of Wisconsin-Madison in an M.D.-Ph.D. program, and received a Ph.D. in marine biology from the Scripps Institution of Oceanography at the University of California-San Diego in 1976. A professor of biology at the Pennsylvania State University from 1976 to 1985, he held an adjunct appointment there until coming to Beloit. His research interests were in the areas of marine and terrestrial plant physiology and ecology. He has served as president of the American Institute of Biological Sciences and is or has been a member of a number of distinguished scientific boards and advisory committees including the Grass Foundation, the Stazione Zoologica “Anton Dohrn” in Naples, Italy, the American Association for the Advancement of Science, and the Radiation Effects Research Foundation in Hiroshima, Japan. He has also served as a consultant to the National Conference of Catholic Bishops' Committee on Science and Human Values.

Arturo Casadevall is the Leo and Julia Forchheimer Professor of Microbiology & Immunology and Chair of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine. He is also a Professor in the Department of Medicine. He received his B.A. from Queens College, CUNY, and M.S., M.D. and Ph.D. degrees from New York University. The laboratory has a multidisciplinary research program spanning several areas of basic immunology and microbiology to address these general questions, which has resulted over 460 publications. His laboratory studies are focused on two microbes: the fungus Cryptococcus neoformans, a ubiquitous environmental microbe that is a frequent cause of disease in immunocompromised individuals and Bacillus anthracis, which a major agent of biological warfare. He is a fellow of the American Academy of Microbiology and was elected to the American Society for Clinical Investigation, to the American Association of Physicians and as a fellow of the AAAS. Dr. Casadevall has served on numerous advisory committees to the NIH including study sections, strategic planning for the NIAID and the blue ribbon panel on response to bioterrorism. He currently co-chairs the Board of Scientific Counselors for the NIAID and is a member of the National Science Advisory Board for Biosecurity (NSABB). He is the founding editor of the first ASM general journal, mBio and serves on the editorial boards of several journals, and has been the recipient of numerous awards, most recently the Solomon A. Berson Medical Alumni Achievement Award in Basic Science-NYU School of Medicine 2005, IDSA Kass Lecturer in 2008 and the ASM William Hinton Award for mentoring scientists from underrepresented groups.

Joel S. Cecil, Ph.D. (Psychology), Northwestern University; J.D., Northwestern University, is a Senior Research Associate and Project Director in the Division of Research at the Federal Judicial Center. Currently he is directing the Center’s Program on Scientific and Technical Evidence. As part of this program he is responsible for judicial education and training in the area of scientific and technical evidence and serves as principal editor of the Center’s Reference Manual on Scientific Evidence which is the primary source book on evidence for federal judges. He has also published several articles on the use of court-appointed experts. He is currently directing a research project that examines the difficulties that arise with expert testimony in federal courts, with an emphasis on clinical medical testimony and forensic science evidence. Other areas of research interest include federal civil and appellate procedure, jury competence in complex civil litigation, and assessment of rule of law in emerging democracies. Dr. Cecil serves on the editorial boards of social science and legal journals and on the National Academies. He previously served on the National Academies Panel on Confidentiality and Data Access. He currently is a member of the National Academies Science, Technology, and Law Panel and was a member of its Subcommittee on Access to Research Data: Balancing Risks and Opportunities.

Rochelle Cooper Dreyfuss is the Pauline Newman Professor of Law at New York University School of Law. She holds B.A. and M.S. degrees in Chemistry and spent several years as a research chemist before entering Columbia University School of Law, where she served as Articles and Book Review Editor of the Law Review. After graduating, she was a law clerk to Chief Judge Wilfred Feinberg of the U.S. Court of Appeals for the Second Circuit and to Chief Justice Warren E. Burger of the U.S. Supreme Court. During her time at NYU School of Law, she has served as the director of the Engelberg Center on Innovation Law and Policy and as a member of the New York City Bar Association, the American Law Institute, and BNA's Advisory Board to USPQ. She was a consultant to the Federal Courts Study Committee, to the Presidential Commission on Catastrophic Nuclear Accidents, and to the Federal Trade Commission. She is a past chair of the Intellectual Property Committee of the American Association of Law Schools.

Professor Dreyfuss served as a member of two National Academy of Sciences Committees, one on Intellectual Property in Genomic and Protein Research and Innovation, the other on Intellectual Property Rights in the Knowledge-Based Economy. She is currently a Reporter for the American Law Institute Project on Intellectual Property: Principles Governing Jurisdiction, Choice of Law, and Judgments in Transnational Disputes. She has visited at the University of Chicago Law School, University of Washington Law School, and Santa Clara School of Law. In addition to articles in her specialty areas, she has co-authored casebooks on civil procedure and intellectual property law.

Marcus Feldman, Ph.D.,is Burnet C. and Mildred Finley Wohlford Professor of Biology at Stanford University and External Professor the Santa Fe Institute. Dr. Feldman’s specific areas of research include the evolution of complex genetic systems that can undergo both natural selection and recombination, the evolution of modern humans using models for the dynamics of molecular polymorphisms, especially DNA variants, and the evolution of learning as one interface between modern methods in artificial intelligence and models of biological processes, including communication. He is the author of more than 440 scientific papers and nine books on evolution, ecology, mathematical biology, and Chinese demography, adding significantly to the greater database over the years.

In 2003, Dr. Feldman’s work received the “Paper of the Year” award for biomedical science from the prestigious medical research journal The Lancet. Dr. Feldman is now working on three books—on gene-culture coevolutionary theory, niche construction in evolutionary biology, and the sex-ratio issue in China—and also serves as academic director of Bridging the Rift, a project to develop collaborations between Israeli and Jordanian scientists. In addition to his teaching, research, writing, and directing, he is managing editor of Theoretical Population Biology and associate editor of Genetics, Human Genetics, Annals of Human Genetics, Annals of Human Biology,and Complexity. He is a former editor of The American Naturalist. Dr. Feldman is a member of the The American Society of Human Genetics and a Fellow of the American Academy of Arts & Sciences and of the California Academy of Sciences. The Hebrew University of Jerusalem and Tel Aviv University have awarded him honorary doctorates of philosophy, and Beijing Normal University and Xi’an Jiaotong University have each appointed him honorary professor.

Alice P. Gast (NAE) became Lehigh University's 13th president on August 1, 2006. Previously she was the Robert T. Haslam Professor of Chemical Engineering and the Vice President for Research and Associate Provost at Massachusetts Institute of Technology. Prior to moving to MIT in 2001, she spent 16 years as a professor of chemical engineering at Stanford University and at the Stanford Synchrotron Radiation Laboratory. In her research she studies surface and interfacial phenomena, in particular the behavior of complex fluids. Some of her areas of research include colloidal aggregation and ordering, protein lipid interactions and enzyme reactions at surfaces. In 1997 Gast co-authored the sixth edition of “Physical Chemistry of Surfaces” with Arthur Adamson. Professor Gast received her BS in Chemical Engineering from the University of Southern California. After earning her Ph.D. in chemical engineering from Princeton University, Gast spent a postdoctoral year on a NATO fellowship at the École Supérieure de Physique et de Chimie Industrielles in Paris. She returned there for a sabbatical as a Guggenheim Fellow. She was a 1999 Alexander von Humboldt Fellow at the Technical University in Garching, Germany. She received the National Academy of Sciences Award for Initiative in Research, and the Colburn Award of the American Institute of Chemical Engineers. She was elected to the National Academy of Engineering in 2001 and to the American Academy of Arts and Sciences in 2002.

Professor Gast has served on numerous advisory committees and boards, including the Board of the American Association for the Advancement of Science (AAAS) and the National Space Biomedical Research Institute Board of Directors. She is a member of the American Chemical Society, the American Institute of Chemical Engineers, the American Physical Society.

Benjamin W. Heineman, Jr. was GE’s Senior Vice President-General Counsel for GE from 1987-2003, and then Senior Vice President for Law and Public Affairs from 2004 until his retirement at the end of 2005. He is currently Distinguished Senior Fellow at Harvard Law School’s Program on the Legal Profession, Senior Fellow at Harvard Law School’s Program on Corporate Governance, Senior Fellow at the Belfer Center for Science and International Affairs at Harvard’s Kennedy School of Government and Lecturer in Law at Yale Law School. A Rhodes Scholar, editor-in-chief of the Yale Law Journal and law clerk to Supreme Court Justice Potter Stewart, Mr. Heineman was assistant secretary for policy at the Department of Health, Education and Welfare and practiced constitutional law prior to his service at GE. His book, High Performance with High Integrity, was published in June, 2008 by the Harvard Business Press. He writes and lectures frequently on business, law, public policy and international affairs. He is also the author of books on British race relations and the American presidency.

He is a member of the American Philosophical Society, a fellow of the American Academy of Arts and Sciences, and recipient of the American Lawyer’s Lifetime Achievement Award and the Lifetime Achievement Award of Board Member Magazine. He was named one of America’s 100 most influential lawyers by the National Law Journal, was named one of the 100 most influential individuals on business ethics by Ethisphere Magazine and was named on of the 100 most influential people in corporate governance by the National Association of Corporate Directors. He serves on the boards of Memorial Sloan Kettering Cancer Center (chair of patient care committee), the Center for Strategic and International Studies (chair of program committee), Transparency International-USA (chair of program committee) and the Committee for Economic Development (chair of the corporate governance committee). He is a member of the board of trustees of Central European University. He is currently on an international panel advising the President of the World Bank on governance and anti-corruption.

He is a graduate of Harvard College (BA – high honors in history), Oxford University (B.Litt) and Yale Law School (JD).

D. Brock Hornby is a United States District Judge in Portland, Maine. Judge Hornby was born in Canada, obtained his B.A. from the University of Western Ontario, and graduated from Harvard Law School where he was Supreme Court Note and Developments Editor of The Harvard Law Review. He clerked for U.S. Fifth Circuit Judge John Minor Wisdom, taught at the University of Virginia Law School (he became a U.S. citizen during that period), practiced with Perkins, Thompson, Hinckley & Keddy in Portland, Maine, served as a United States Magistrate Judge, then as a Justice of the Maine Supreme Judicial Court and became a United States District Judge in 1990. He is a member of the Council of The American Law Institute. He is a fellow of the American and Maine Bar Foundations. He is a member of the National Academies' standing Committee on Science, Technology and the Law. He has served on both the United States Judicial Conference and its Executive Committee. Previously the Chief Justice appointed him chair of The Federal Judicial Center’s Committee on District Judge Education, chair of the United States Judicial Conference Committee on Court Administration and Case Management, and member of the Judicial Conduct and Disability Act Study Committee (the Breyer Committee) to study the system of judicial discipline for federal judges. Currently, the Chief Justice has appointed him chair of the Judicial Conference Committee on the Judicial Branch and chair of an Ad Hoc Committee to secure judicial salary restoration. In 2009, Judge Hornby received the 27th Annual Edward J. Devitt Distinguished Service to Justice Award. Judge Hornby has presided over major Multidistrict Litigation (MDL) antitrust and data theft class lawsuits. He has been a lecturer or consultant on United States judicial topics to judges in Argentina, Canada, China, the Czech Republic, England, Moldova and Thailand. Apart from his judicial opinions, he has written on a variety of legal and judicial topics.

David Korn (IOM), B.A., scl, M.D., cl, Harvard University, is presently Consultant in Pathology at the Massachusetts General Hospital and Professor of Pathology at Harvard Medical School. From November 15, 2008 to June 30, 2011, he was the inaugural Vice-Provost for Research at Harvard University. Prior to joining Harvard, Dr. Korn had served as the Chief Scientific Officer of the Association of American Medical Colleges (AAMC) in Washington, D.C. since January 15, 2007, and before that as the Senior Vice President for Biomedical and Health Sciences Research at the Association since September 1, 1997.

Dr. Korn served as Carl and Elizabeth Naumann Professor and Dean of the Stanford University School of Medicine from October 1984 to April 1995, and as Vice President of Stanford University from January 1986 to April 1995. Previously, he had served as Professor and Chairman of the Department of Pathology at Stanford, and Chief of the Pathology Service at the Stanford University Hospital, since June 1968. Dr. Korn has been Chairman of the Stanford University Committee on Research; President of the American Association of Pathologists (now the American Society for Investigative Pathology), from which he received the Gold-Headed Cane Award for lifetime achievement in 2004; President of the Association of Pathology Chairman, from which he received the Distinguished Service Award in 1999; a member of the Board of Directors and of the Executive Committee of the Federation of American Societies for Experimental Biology; and a member of the Board of Directors of the Association of Academic Health Centers.

Dr. Korn was a founder and Chairman of the Board of Directors of the California Transplant Donor Network, one of the nation’s largest Organ Procurement Organizations. Later, he was a founder of the nonprofit Association for the Accreditation of Human Research Protection Programs, created to enhance and standardize the protection of human research participants. He has been a member of the Institute of Medicine of the National Academies of Science since 1989, has served on many NAS and IOM committees, was a founder of the IOM’s Clinical Research Roundtable, and is currently co-chair of the NAS Committee on Science, Technology and Law. In 1996-97 Dr. Korn chaired a Special Subcommittee of the Science Board of the Food and Drug Administration to Review the FDA’s Intramural Research Program, for which he received the Commissioner’s Special Citation and the Harvey W. Wiley Medal. From 1984 to 1991 he served as Chairman of the National Cancer Advisory Board, a position to which he was appointed by President Reagan. Dr. Korn is a Fellow of the AAAS and has served on its Council, and he was a member of the University Grants Committee of Hong Kong from 1998-2004, where he was Chairman of the Medical Subcommittee.

Dr. Korn served on the Boards of Directors of the Stanford University Hospital from October 1982 to April 1995, the Children’s Hospital at Stanford from October 1984 to its closure, and the Lucile Salter Packard Children’s Hospital at Stanford from October 1984 to April 1995. He was a member of the Board of Directors of the California Society of Pathologists from 1983-86.

Dr. Korn has been a member of the editorial boards of the American Journal of Pathology, The Journal of Biological Chemistry, and Human Pathology, and for many years was an Associate Editor of the latter. He has sat on many Society Councils and Boards. His more than 250 publications range from bacteriophage biochemistry and genetics to the biochemistry and molecular biology of DNA replication in human cells, and more recently, concern issues of academic values and integrity, research integrity, health and science policy, and financial conflicts of interest in academic medicine.

David Korn, M.D. (IOM) is Professor of Pathology at Harvard Medical School. Formerly, he was the Inaugural Vice Provost for Research of Harvard University. Prior to that he was senior vice president for biomedical and health sciences research at the Association of American Medical Colleges in Washington, D.C., a position he assumed on September 1, 1997. Dr. Korn served as Carl and Elizabeth Naumann Professor and Dean of the Stanford University School of Medicine from October 1984 to April 1995, and as Vice President of Stanford University from January 1986 to April 1995. Before that he had served as Professor and Chairman of the Department of Pathology at Stanford, and Chief of the Pathology Service at the StanfordUniversityHospital, since June 1968. Dr. Korn has been Chairman of the Stanford University Committee on Research; President of the American Association of Pathologists (now the American Society for Investigative Pathology), from which he received the Gold-Headed Cane award for lifetime achievement in 2004; and from 1984-91 was Chairman of the National Cancer Advisory Board, a Presidential appointment. Dr. Korn, who is a Fellow of the AAAS, was a founder and Chairman of the Board of Directors of the California Transplant Donor Network, one of the nation's largest Organ Procurement Organizations, and a founder of the Association for the Accreditation of Human Research Protection programs. He is a member of the Institute of Medicine of the National Academy of Sciences, and was a founder of the Clinical Research Roundtable. Dr. Korn served on the Boards of Directors of the StanfordUniversityHospital from October 1982 to April 1995, the Children's Hospital at Stanford from October 1984 to its closure, and the Lucile Salter Packard Children's Hospital at Stanford from October 1984 to April 1995. He was a member of the Board of Directors of the California Society of Pathologists from 1983-86. He has been a member of many National Academies’ committees and has been a member of the NAS’ committee on Science, Technology, and Law since its inception.

Richard A. Meserve (NAE), J.D., Harvard Law School; Ph.D. (Applied Physics) Stanford University; B.A., Tufts University, is President of the Carnegie Institution for Science. Before assuming the Carnegie presidency in April 2003, he was Chairman of the U.S. Nuclear Regulatory Commission (NRC), having served since October 1999. Before joining the NRC, Dr. Meserve was a partner in the law firm of Covington & Burling, where he now serves on a part-time basis as a Senior Of Counsel. He devoted his legal practice to technical issues arising in environmental and toxic tort litigation, counseling scientific societies and high-tech companies, and nuclear licensing. Early in his career, he served as legal counsel to the President’s science advisor, and was a law clerk to Justice Harry A. Blackmun of the United States Supreme Court and to Judge Benjamin Kaplan of the Massachusetts Supreme Judicial Court. He is a member of the National Academy of Engineering and the American Philosophical Society and a Fellow of the American Academy of Arts and Sciences, the American Association for the Advancement of Sciences, and the American Physical Society. He currently serves as Chairman of the International Nuclear Safety Group, chartered by the International Atomic Energy Agency, and as a member of the National Commission on Energy Policy and the Blue-Ribbon Commission on America’s Energy Future. He is also a member of the Board of Overseers of Harvard University. He has previously served on numerous committees and boards of the National Academies, now serving as Chairman of the Nuclear and Radiation Safety Board. Dr. Meserve also serves on the boards of PG&E Corporation and Luminant Holding Company LLP. He wrote the amicus briefs on behalf of the National Academy of Engineering in the Kumho case and on behalf of the National Academy of Sciences in the Daubert case. These landmark cases established the basis for admitting expert testimony into court.

Alan B. Morrison, LL.B., Harvard Law School, spent most of his professional career at the Public Citizen Litigation Group in Washington, D.C., which he founded with Ralph Nader in 1972. He is currently the Associate Dean for Public Interest and Public Service at the George Washington University School of Law. Mr. Morrison was Special Counsel to the Attorney General for the District of Columbia from September 2007 to January 2008. Before becoming Special Counsel to the Attorney General, he spent three years as a Senior Lecturer at Stanford Law School where he has taught courses in the fields of litigation, administrative law and legal ethics. He has also taught at the law schools at Harvard, NYU and the University of Hawaii and is a member of the American Law Institute. Prior to his work at Public Citizen he was an associate in a law firm and an Assistant U.S. Attorney in New York City. Mr. Morrison was a commissioned officer in the U.S. Navy after he graduated from Yale College. In 1999-2000 he was President of the American Academy of Appellate Lawyers. Mr. Morrison has served two previous terms on the National Academies Science, Technology, and Law Panel, and was a member of its Subcommittee on Ensuring the Quality of Information Disseminated by the Federal Government.

Prabhu Pingali (NAS) is the Deputy Director of Agricultural Development at the Bill and Melinda Gates Foundation. Formerly, he served as Director of the Agricultural and Development Economics Division of the Food and Agriculture Organization (FAO) of the United Nations. Dr. Pingali was elected to the U.S. National Academy of Sciences as a Foreign Associate in May 2007, and he was elected Fellow of the American Agricultural Economics Association in 2006. Dr. Pingali was the President of the International Association of Agricultural Economists (IAAE) from 2003-06.

Dr. Pingali has over twenty five years of experience in assessing the extent and impact of technical change in agriculture in developing countries, including Asia, Africa and Latin America. From 1996-2002 he was Director of the Economics Program at CIMMYT, Mexico. Prior to joining CIMMYT, from 1987 to 1996, he worked as an Agricultural Economist at the International Rice Research Institute at Los Baños, Philippines. Prior to that, he worked from 1982-1987 as an economist at the World Bank’s Agriculture and Rural Development Department. Dr. Pingali has been a visiting scholar at Stanford University’s Food Research Institute, and an Affiliate professor at the University of the Philippines at Los Baños.

Dr. Pingali has authored nine books and over one hundred referred journal articles and book chapters on technological change, productivity growth and resource management issues in Asia, Africa and Latin America. He has received several international awards for his work, including two from the American Agricultural Economics Association: Quality of Research Discovery Award in 1988 and Outstanding Journal Article of the Year (Honorable Mention) in 1995. An Indian national, he earned a Ph.D. in Economics from North Carolina State University in 1982.

Harriet Rabb was at Columbia Law School as a clinical professor, head of the clinical program and a member of the faculty during the course of her affiliation of more than two decades there. In 1991, she was named the first George M. Jaffin Professor of Law and Social Responsibility and, in 1992, added the title of vice dean of the law faculty. In 1998, she was the recipient of the Law School’s Lawrence A. Wien Prize for Social Responsibility.

In 1993, Ms. Rabb was confirmed by the United States Senate to serve as general counsel for the U.S. Department of Health and Human Services under Secretary Donna Shalala. As chief legal officer of the Department, Ms. Rabb was responsible for legal matters involving, among other agencies, the National Institutes of Health, the Centers for Disease Control, the Food and Drug Administration, the Health Care Financing Administration and the Administration for Children and Families. Ms. Rabb led the Department’s legal efforts on health policy issues, including human stem cell research, pandemic influenza, tobacco, assisted reproductive technology, tissue and organ allocation, fetal tissue and human embryo research, informed consent and various aspects of vaccines.

In 2001, Ms. Rabb was named to her current position as vice president and general counsel to The Rockefeller University.

David S. Tatel, B.A., University of Michigan (1963); J.D., University of Chicago Law School (1966), is a judge on the United States Court of Appeals for the District of Columbia Circuit. Before this appointment by President Clinton in 1994, Tatel was for fifteen years partner and head of the education group at Hogan & Hartson in Washington, D.C. From 1977 to 1979 he was director of the Office for Civil Rights in the U.S. Department of Health, Education and Welfare under President Carter. Judge Tatel was a member of the Board of Directors for the Spencer Foundation, which he chaired from 1990 to 1997, and he is currently a member of the Board of Directors for the Carnegie Foundation for the Advancement of Teaching, which he chaired from 2006 to 2009.

Sophie Vandebroek has been Xerox’s Chief Technology Officer and the President of the Xerox Innovation Group since January 2006. She is responsible for overseeing Xerox’s research centers in Europe, Asia, Canada and US as well as the Palo Alto Research Center (PARC Inc.).

Between 2002 and 2004, Dr. Vandebroek was Chief Engineer of Xerox Corporation and Vice President of the Xerox Engineering Center. Prior to that, she served as Chief Technology Officer at Carrier Corp. From 1991 until 2000, she held a number of increasingly responsible roles at Xerox including technical advisor to Xerox's chief operating officer and Director of the Xerox Research Centre of Canada.

Dr. Vandebroek is a Fellow of the Institute of Electrical & Electronics Engineers, a Fulbright Fellow and a Fellow of the Belgian-American Educational Foundation. She holds 12 US patents. Dr. Vandebroek has received awards from Xerox, IBM, HP, Monsanto, the Belgium National Science Foundation, Semiconductor Research Corporation, IEEE, and Cornell University. She served as a judge for MIT’s Technology Review Young Innovators awards, the Wall Street Journal Innovation awards and the FIRST Lego and Robotics competition regional awards.

Dr. Vandebroek is a member of the Board of Directors of Analogic Corporation and Nypro Corporation. She is a trustee of Worcester Polytechnic Institute (WPI) and serves on the advisory councils of the deans of Engineering at Cornell University and at MIT. Vandebroek was born in Leuven, Belgium where she earned a master's degree in electro-mechanical engineering from Katholieke Universiteit, Leuven, Belgium. She received her Ph.D. in electrical engineering from Cornell University, Ithaca, NY.

CSTL STAFF BIOGRAPHIES

Anne-Marie Mazza, Director. B.A., Economics; M.A., History and Public Policy; Ph.D., Public Policy, The George Washington University. Dr. Mazza joined the National Academies in 1995. She has served as Senior Program Officer with both the Committee on Science, Engineering and Public Policy and the Government-University-Industry Research Roundtable. In 1999 she was named the first director of the Science, Technology, and Law Program. Between October 1999 and October 2000, she divided her time between the STL Program and the White House Office of Science and Technology Policy, where she served as a Senior Policy Analyst.
Voice: 202-334-2469
E-mail: amazza@nas.edu
Fax: 202-334-2530

Steven Kendall, Associate Program Officer. B.A., Art History, Kent State University; M.A. Victorian Art & Architecture, University of London, Ph.D., Art History, University of California, Santa Barbara. Dr. Kendall has contributed to numerous Academy reports including Review of the Scientific Approaches Used During the FBI’s Investigation of the 2001 Anthrax Mailings (2011), Managing University Intellectual Property in the Public Interest (2010); and Strengthening Forensic Science in the United States: A Path Forward (2009). Prior to joining The National Academies in 2007, he worked at the Smithsonian American Art Museum and The Huntington in San Marino, California.
Voice: 202-334-1713
E-mail: skendall@nas.edu
Fax: 202-334-2530

UPCOming Events